• Something wrong with this record ?

Report of Consensus Panel 2 from the 12th International Workshop on the management of Bing-Neel syndrome in patients with Waldenstrom's Macroglobulinemia

S. Sarosiek, AL. Becking, A. Branagan, S. Ferrero, J. Khwaja, E. Kimby, D. Roos-Weil, N. Sekiguchi, M. Trneny, S. Yi, CJ. Patterson, C. Buske, JV. Matous, SP. Treon, MC. Minnema

. 2025 ; 62 (2) : 85-89. [pub] 20250416

Language English Country United States

Document type Consensus Development Conference, Journal Article

Persistent link   https://www.medvik.cz/link/bmc25016196

Consensus panel 2 from the 12th International Workshop on Waldenstrom Macroglobulinemia was tasked with updating the guidelines on the diagnosis and management of patients with Bing-Neel syndrome (BNS). In this panel we have summarized the clinical symptoms that may be present with BNS, discussed the criteria required for diagnosis of BNS, made recommendations for follow-up imaging, and proposed revised guidelines for response assessment in BNS. The key recommendations from the 12th International Workshop on WM (IWWM-12) Consensus panel 2 include: (1) the establishment of zanubrutinib as a standard therapy for treatment of BNS; (2) recommendations on imaging and CSF evaluation during treatment and follow-up of BNS; and (3) revised response criteria in view of new data showing that malignant cells can persist in the CSF of many patients treated with BTK-inhibitors. New categorical response categories proposed include that for a Clinical Complete Response and Progressive Disease.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25016196
003      
CZ-PrNML
005      
20250731091607.0
007      
ta
008      
250708s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1053/j.seminhematol.2025.04.005 $2 doi
035    __
$a (PubMed)40414752
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Sarosiek, Shayna $u Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address: shayna_sarosiek@dfci.harvard.edu
245    10
$a Report of Consensus Panel 2 from the 12th International Workshop on the management of Bing-Neel syndrome in patients with Waldenstrom's Macroglobulinemia / $c S. Sarosiek, AL. Becking, A. Branagan, S. Ferrero, J. Khwaja, E. Kimby, D. Roos-Weil, N. Sekiguchi, M. Trneny, S. Yi, CJ. Patterson, C. Buske, JV. Matous, SP. Treon, MC. Minnema
520    9_
$a Consensus panel 2 from the 12th International Workshop on Waldenstrom Macroglobulinemia was tasked with updating the guidelines on the diagnosis and management of patients with Bing-Neel syndrome (BNS). In this panel we have summarized the clinical symptoms that may be present with BNS, discussed the criteria required for diagnosis of BNS, made recommendations for follow-up imaging, and proposed revised guidelines for response assessment in BNS. The key recommendations from the 12th International Workshop on WM (IWWM-12) Consensus panel 2 include: (1) the establishment of zanubrutinib as a standard therapy for treatment of BNS; (2) recommendations on imaging and CSF evaluation during treatment and follow-up of BNS; and (3) revised response criteria in view of new data showing that malignant cells can persist in the CSF of many patients treated with BTK-inhibitors. New categorical response categories proposed include that for a Clinical Complete Response and Progressive Disease.
650    _2
$a lidé $7 D006801
650    _2
$a proteinkinasa BTK $x antagonisté a inhibitory $7 D000077329
650    _2
$a konsensus $7 D032921
650    _2
$a management nemoci $7 D019468
650    _2
$a piperidiny $x terapeutické užití $7 D010880
650    _2
$a inhibitory proteinkinas $x terapeutické užití $7 D047428
650    _2
$a pyrazoly $x terapeutické užití $7 D011720
650    _2
$a pyrimidiny $x terapeutické užití $7 D011743
650    12
$a Waldenströmova makroglobulinemie $x diagnóza $x terapie $x farmakoterapie $7 D008258
655    _2
$a konsensus - konference $7 D016446
655    _2
$a časopisecké články $7 D016428
700    1_
$a Becking, Anne-Marie L $u Amsterdam University Medical Centers, Cancer Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands
700    1_
$a Branagan, Andrew $u Massachusetts General Hospital Cancer Center, Boston MA
700    1_
$a Ferrero, Simone $u Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy
700    1_
$a Khwaja, Jahanzaib $u Centre for Waldenström Macroglobulinaemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, UK
700    1_
$a Kimby, Eva $u Division of Hematology, department of Medicine, Karolinska Institutet Huddinge, Stockholm, Sweden
700    1_
$a Roos-Weil, Damien $u Hematology Department, Sorbonne University, Pitié-Salpêtrière hospital, Paris, France
700    1_
$a Sekiguchi, Naohiro $u Hematology Division, National Hospital Organization Disaster Medical Center, Tokyo, Japan
700    1_
$a Trneny, Marek $u First Department of Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, Czech Republic
700    1_
$a Yi, Shuhua $u State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, China and Tianjin Institutes of Health Science, Tianjin, China
700    1_
$a Patterson, Christopher J $u Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
700    1_
$a Buske, Christian $u Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany
700    1_
$a Matous, Jeffrey V $u Colorado Blood Cancer Institute, Sarah Cannon Research Institute, Denver, CO
700    1_
$a Treon, Steven P $u Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
700    1_
$a Minnema, Monique C $u Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
773    0_
$w MED00004323 $t Seminars in hematology $x 1532-8686 $g Roč. 62, č. 2 (2025), s. 85-89
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40414752 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250708 $b ABA008
991    __
$a 20250731091601 $b ABA008
999    __
$a ok $b bmc $g 2366794 $s 1253321
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 62 $c 2 $d 85-89 $e 20250416 $i 1532-8686 $m Seminars in hematology $n Semin Hematol $x MED00004323
LZP    __
$a Pubmed-20250708

Find record

Citation metrics

Archiving options